Modular Syringe Pump Components are pumping modules which allow OEM manufacturers or research do-it-yourselfers to incorporate quality pumping modules.
Multi Filling Systems integrate peristaltic technology into a seamless process in which the sterile product comes into contact with only the medically graded silicone tubing and filling needle.
DAFPA disposable aseptic fluid path is a ready to use system that incorporates a gamma irradiated sterile flexible product bag, sterile filter and peristaltic pump tubing assembly with nozzle. The pre-sterilized assembly is opened within a sterile area at point of use and installed.
Inert bottle caps sparge, filter and transfer highly aggressive fluids from storage bottles to the inlets of an automated chromatography instrument. The fluids have to be sparged and filtered to ensure that bubbles or particles do not block sensitive instrument components.
The Autolab ESPRIT surface plasmon resonance (SPR) system offers the option of simultaneous electrochemical and SPR measurements. Dual channels, one for samples and one for reference, are provided.
MVS Multichannel Verification System provides a reliable, accurate method for calibrating automated liquid handling equipment. A dual-dye, dual-wavelength, ratiometric absorbance method is used to provide verification of liquid dispensing.
Programmable Pipet-Aid Elite 400 hand-held pipettors features programming functions that enable quick volume setting based on pipet size. The unit can accommodate a range of pipet sizes from 1 to 50 ml, and will reproducibly dispense volumes as small as 0.1 ml.
Signature Pipettors are available in variable-volume, fixed-volume and multichannel models, and offer accuracy and comfortable handle design. The pipettors cover the range from 0.2 to 5000 μl in nine single channel units.
A new drug with a new target
Microarrays yield a 115-gene signature
CDC Released Misleading Obesity Stats
Matching binding compounds to targets
How it works and for who?
Shakedown at the FDA Under intense public scrutiny following the withdrawal of Vioxx from the market based on evidence of increased heart attack and stroke, the FDA is now defending its role as an independent and unbiased protector of the public against dangerous drugs.